PALATIN TECHNOLOGIES, INC. Recognition of Deferred Revenue
PALATIN TECHNOLOGIES, INC. (PTN) reported Recognition of Deferred Revenue of $11.91 million for the 12-month period ending 2010-06-30, per its 10-K filed 2012-09-10.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2012-09-10
- PALATIN TECHNOLOGIES, INC. recognition of deferred revenue for fiscal 2010 was $11.91M.
| Period end | Recognition of Deferred Revenue 12 month |
|---|---|
| 2010-06-30 | $11.91M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |